Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-14 4:40 pm Unchanged | 13D | SPERO THERAPEUTICS INC SPRO | GSK plc GSK | 1,934,006 10.1% | 0 (Unchanged) | View |
| 2020-02-14 4:39 pm Purchase | 13D | PRINCIPIA BIOPHARMA INC PRNB | GSK plc GSK | 3,042,193 9.3% | 387,857 (+14.61%) | View |
| 2020-02-14 4:39 pm Sale | 13G | GENOCEA BIOSCIENCES INC GNCA | GSK plc GSK | 3,676,767 7.7% | -10,880,237 (-74.74%) | View |
| 2020-02-14 4:39 pm Purchase | 13G | PROGYNY INC PGNY | GSK plc GSK | 10,526,957 12.5% | 10,526,957 (New Position) | View |
| 2020-02-14 4:38 pm Unchanged | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | GSK plc GSK | 1,915,275 10.7% | 0 (Unchanged) | View |
| 2020-02-14 4:38 pm Sale | 13D | AILERON THERAPEUTICS INC ALRN | GSK plc GSK | 504,926 1.8% | -926,593 (-64.73%) | View |
| 2020-02-14 4:38 pm Sale | 13D | APPLIED GENETIC TECHNOLOGIES C AGTC | GSK plc GSK | 0 0% | -1,436,448 (Position Closed) | View |
| 2020-02-14 4:10 pm Purchase | 13G | FULCRUM THERAPEUTICS INC FULC | GSK plc GSK | 1,785,714 7.7% | 1,785,714 (New Position) | View |
| 2020-02-14 4:09 pm Purchase | 13D | CRISPR THERAPEUTICS AG NAMEN A CRSP | GSK plc GSK | 3,295,627 5.5% | 30,000 (+0.92%) | View |
| 2020-02-05 12:00 pm Purchase | 13G | GSK PLC SPONSORED ADR GSK | BlackRock Inc. BLK | 376,159,235 7.5% | 31,949,465 (+9.28%) | View |
| 2019-07-25 3:39 pm Unchanged | 13D | MORPHIC HLDG INC MORF | GSK plc GSK | 2,633,772 8.9% | 0 (Unchanged) | View |
| 2019-07-12 4:23 pm Purchase | 13D | MORPHIC HLDG INC MORF | GSK plc GSK | 2,633,772 8.9% | 2,633,772 (New Position) | View |
| 2019-06-07 2:04 pm Purchase | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | GSK plc GSK | 1,915,275 10.8% | 1,915,275 (New Position) | View |
| 2019-05-10 2:56 pm Purchase | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | GSK plc GSK | 12,455,252 14.5% | 12,455,252 (New Position) | View |
| 2019-05-03 10:47 am Sale | 13D | TRANSLATE BIO INC TBIO | GSK plc GSK | 3,197,913 7.06% | -499,999 (-13.52%) | View |